NEW YORK, May 21 (GenomeWeb News) - Pharmacopeia has changed its name to Accelrys, the company said yesterday.

 

Stockholders approved the name change on May 11. After spinning off its drug discovery business, Accelrys is now solely focused on delivering scientific software to the life science and materials research industries.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.